- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04635124
Optimal Dog Visits
The aim of this project is to study how an the intensity of dog contact during dog visits in nursing homes can affect the immediate response to, and the general effect of the visits, and whether the residents' level of cognitive impairment affects the response and benefit of dog visits.
The participants are randomly assigned to receive one type of visits (12 visits in total) out of three possible visit types (1: visit with a dog; 2: visit with a dog, including a planned activity, 3 visit without a dog, including a planned activity). The residents received 2 visits per week for 6 weeks. The behaviour of the participants during visits is recorded. Before and after the intervention period, participants are scores on psychometric scales for cognitive impairment level, daily function level and symptoms of depression.
Study Overview
Status
Intervention / Treatment
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
• Being able to sit up during the visits
Exclusion Criteria:
- Dog allergy
- Fear of dogs
- Health problems that make participation unadvisable
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Basic Science
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: 1: Dog visit with a dog, no additional activity (D)
The nursing home resident receives 12 10-minute visits in their own room.
The visitor is accompanied with a dog, and the resident can touch the dog.
Apart from the visitor, an observer is present.
|
An visitor visits the participant with a dog
|
|
Experimental: 2: Dog visit with an additional activity (DA)
The nursing home resident receives 12 10-minute visits in their own room. The visitor is accompanied with a dog, and the resident can touch the dog. During the visit, the visitor offers the resident to participate in an activity that involves interacting with the dog. Apart from the visitor, an observer is present. |
An visitor visits the participant with a dog
In each visit the visitor invites the participant to engage in an activitty
|
|
Active Comparator: 3: Visit without dog, with an additional activity (A)
The nursing home resident receives 12 10-minute visits in their own room. During the visit, the visitor offers the resident to participate in an activity. Apart from the visitor, an observer is present, but no dog is present.. |
In each visit the visitor invites the participant to engage in an activitty
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Behavioural response during visits
Time Frame: Behaviour is recorded in all of the 12 visits in the 6 week intervention period
|
The behaviour of the residents is recorded by direct observation using continuous recording.
In all visits, the frequency and duration of talk and physical contact to the persons present are recorded.
Talk is classified into talk about the dog and/or activity, depending on the visit type.
In visits with dogs (D, DA), the frequency and duration of physical contact and talk directed to the dog are recorded, and in visits involving an activity (DA, A), the frequency and duration of the residents' involvement in the activity are recorded.
|
Behaviour is recorded in all of the 12 visits in the 6 week intervention period
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Cognitive impairment level, before intervention
Time Frame: This measure is obtained in the week preceeding the intervention period (6 weeks, 2 visits )
|
All participants were scored on the Mini-Mental State Examination (MMSE), which gives information about the participants' cognitive status.The MMSE score has a minimum and maximum value of 0 and 30, respectively.
The lower the score, the more severe the cognitively impairment level.
|
This measure is obtained in the week preceeding the intervention period (6 weeks, 2 visits )
|
|
Daily function level, before intervention
Time Frame: This measure is obtained in the week preceeding the intervention period (6 weeks, 2 visits )
|
All participants were scored on The Gottfries-Bråne-Steen Scale (GBS), which is an evaluation of disabilities, language, psychiatric symptoms, average daily living function, and behaviour of the participants.
The GBS score has a minimum and maximum value of 0 and 156, respectively.
The lower the score, the more well-functioning the patient.
|
This measure is obtained in the week preceeding the intervention period (6 weeks, 2 visits )
|
|
Symptoms of depression, before intervention
Time Frame: This measure is obtained in the week preceeding the intervention period (6 weeks, 2 visits )
|
All participants were scored on the Geriatric Depression Scale (GDS), to screen for symptoms of depression.
The GDS score has a minimum and maximum value of 0 and 15, respectively.A high score indicates more symptoms of depression.
|
This measure is obtained in the week preceeding the intervention period (6 weeks, 2 visits )
|
|
Cognitive impairment level, after intervention
Time Frame: This measure is obtained in the week following the intervention period (6 weeks, 2 visits )
|
All participants were scored on the Mini-Mental State Examination (MMSE), which gives information about the participants' cognitive status.
The MMSE score has a minimum and maximum value of 0 and 30, respectively.
The lower the score, the more severe the cognitively impairment level.
|
This measure is obtained in the week following the intervention period (6 weeks, 2 visits )
|
|
Daily function level,, after intervention
Time Frame: This measure is obtained in the week following the intervention period (6 weeks, 2 visits )
|
All participants were scored on The Gottfries-Bråne-Steen Scale (GBS), which is an evaluation of disabilities, language, psychiatric symptoms, average daily living function, and behaviour of the participants.
The GBS score has a minimum and maximum value of 0 and 156, respectively.
The lower the score, the more well-functioning the patient.
|
This measure is obtained in the week following the intervention period (6 weeks, 2 visits )
|
|
Symptoms of depression, after intervention
Time Frame: This measure is obtained in the week following the intervention period (6 weeks, 2 visits )
|
All participants were scored on the Geriatric Depression Scale (GDS), to screen for symptoms of depression.
The GDS score has a minimum and maximum value of 0 and 15, respectively.A high score indicates more symptoms of depression.
|
This measure is obtained in the week following the intervention period (6 weeks, 2 visits )
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Karen Thodberg, University of Aarhus
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- Optimal dog visits
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Dementia
-
Benjamin Rose Institute on AgingNational Institute on Aging (NIA)RecruitingMild Dementia | Moderate DementiaUnited States
-
Yaolin PeiNational Institutes of Health (NIH)RecruitingEnd of Life Decision Making | Dementia Caregivers | Advanced DementiaUnited States
-
Benuvia Therapeutics Inc.MandaraNot yet recruiting
-
University of North Carolina, Chapel HillNational Institute on Aging (NIA)CompletedAlzheimer Dementia | Dementia Alzheimers | CaregiverUnited States
-
Temple UniversityCompletedDementia | Mild Cognitive Impairment | Dementia, Vascular | Dementia, Mixed | Dementia Alzheimers | Mild Dementia | Dementia of Alzheimer Type | Dementia, MildUnited States
-
Hebrew SeniorLifeActive, not recruitingAging | Alzheimer Dementia | Presenile Alzheimer DementiaUnited States
-
Temple UniversityCompletedDementia | Alzheimer Disease | Mild Cognitive Impairment | Dementia, Vascular | Dementia, Mixed | Dementia Alzheimers | Mild Dementia | Dementia of Alzheimer Type | Dementia, MildUnited States
-
The University of Hong KongNot yet recruiting
-
National Tainan Junior College of NursingCompletedCognitive Impairment | Dementia, Mild | Dementia ModerateTaiwan
-
Karen RobertoNational Institute on Aging (NIA)RecruitingDementia | Dementia Alzheimers | Neuro-Degenerative Disease | Dementia of Alzheimer Type | Dementia SevereUnited States
Clinical Trials on Dog visit
-
University Hospital, Clermont-FerrandNot yet recruitingDog Therapy | Intensive Care Unit (ICU) PatientsFrance
-
University of SaskatchewanRoyal University Hospital FoundationCompletedPain | Pain, Acute | Pain, Chronic | Pain, IntractableCanada
-
Kaiser PermanenteSeattle Children's HospitalActive, not recruitingPediatric Cancer, Animal-Assisted ActivitiesUnited States
-
University of LouisvilleCompletedThe Impact of Therapy Dogs on Anxiety and Emotional Management in the Pediatric Emergency DepartmentAnxiety | Emotional RegulationUnited States
-
Copenhagen Studies on Asthma in ChildhoodCompleted
-
University of AarhusCompletedPhysiological Stress Responses to Standardises Stress Situations | Psychological Responses to Standardised Stress Situations | Behavioural Responses to Standardised Stress SituationsDenmark
-
Indiana UniversityCompletedAnxiety | Children | Opioid Use | Therapy DogUnited States
-
Swiss Tropical & Public Health InstituteUniversity of BaselCompleted
-
University of Maryland, BaltimoreCompletedPost Traumatic Stress DisorderUnited States
-
Boston Medical CenterBoston Medical Center Healing Pups ProgramRecruitingAnger | Depression | Pain | Anxiety | Trauma InjuryUnited States